185 related articles for article (PubMed ID: 26048536)
1. Growth hormone therapy and risk of recurrence/progression in intracranial tumors: a meta-analysis.
Shen L; Sun CM; Li XT; Liu CJ; Zhou YX
Neurol Sci; 2015 Oct; 36(10):1859-67. PubMed ID: 26048536
[TBL] [Abstract][Full Text] [Related]
2. Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy.
Olsson DS; Buchfelder M; Schlaffer S; Bengtsson BA; Jakobsson KE; Johannsson G; Nilsson AG
Eur J Endocrinol; 2009 Nov; 161(5):663-9. PubMed ID: 19734242
[TBL] [Abstract][Full Text] [Related]
3. Physiologic Growth Hormone-Replacement Therapy and Craniopharyngioma Recurrence in Pediatric Patients: A Meta-Analysis.
Alotaibi NM; Noormohamed N; Cote DJ; Alharthi S; Doucette J; Zaidi HA; Mekary RA; Smith TR
World Neurosurg; 2018 Jan; 109():487-496.e1. PubMed ID: 28987837
[TBL] [Abstract][Full Text] [Related]
4. Safety of Growth Hormone Replacement Therapy in Childhood-Onset Craniopharyngioma: A Systematic Review and Cohort Study.
van Schaik J; Kormelink E; Kabak E; van Dalen EC; Schouten-van Meeteren AYN; de Vos-Kerkhof E; Bakker B; Fiocco M; Hoving EW; Tissing WJE; van Santen HM
Neuroendocrinology; 2023; 113(10):987-1007. PubMed ID: 37231961
[TBL] [Abstract][Full Text] [Related]
5. Long-term safety of growth hormone replacement after CNS irradiation.
Mackenzie S; Craven T; Gattamaneni HR; Swindell R; Shalet SM; Brabant G
J Clin Endocrinol Metab; 2011 Sep; 96(9):2756-61. PubMed ID: 21715535
[TBL] [Abstract][Full Text] [Related]
6. Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence.
Losa M; Castellino L; Pagnano A; Rossini A; Mortini P; Lanzi R
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112101
[TBL] [Abstract][Full Text] [Related]
7. Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up.
Olsson DS; Buchfelder M; Wiendieck K; Kremenevskaja N; Bengtsson BÅ; Jakobsson KE; Jarfelt M; Johannsson G; Nilsson AG
Eur J Endocrinol; 2012 Jun; 166(6):1061-8. PubMed ID: 22457235
[TBL] [Abstract][Full Text] [Related]
8. The effect of growth hormone replacement in patients with hypopituitarism on pituitary tumor recurrence, secondary cancer, and stroke.
Jasim S; Alahdab F; Ahmed AT; Tamhane SU; Sharma A; Donegan D; Nippoldt TB; Murad MH
Endocrine; 2017 May; 56(2):267-278. PubMed ID: 27815769
[TBL] [Abstract][Full Text] [Related]
9. GH and Childhood-onset Craniopharyngioma: When to Initiate GH Replacement Therapy?
Nguyen Quoc A; Beccaria K; González Briceño L; Pinto G; Samara-Boustani D; Stoupa A; Beltrand J; Besançon A; Thalassinos C; Puget S; Blauwblomme T; Alapetite C; Bolle S; Doz F; Grill J; Dufour C; Bourdeaut F; Abbou S; Guerrini-Rousseau L; Leruste A; Brabant S; Cavadias I; Viaud M; Boddaert N; Polak M; Kariyawasam D
J Clin Endocrinol Metab; 2023 Jul; 108(8):1929-1936. PubMed ID: 36794424
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control.
Packer RJ; Boyett JM; Janss AJ; Stavrou T; Kun L; Wisoff J; Russo C; Geyer R; Phillips P; Kieran M; Greenberg M; Goldman S; Hyder D; Heideman R; Jones-Wallace D; August GP; Smith SH; Moshang T
J Clin Oncol; 2001 Jan; 19(2):480-7. PubMed ID: 11208842
[TBL] [Abstract][Full Text] [Related]
11. Tumor Recurrence or Regrowth in Adults With Nonfunctioning Pituitary Adenomas Using GH Replacement Therapy.
van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
J Clin Endocrinol Metab; 2015 Aug; 100(8):3132-9. PubMed ID: 26057181
[TBL] [Abstract][Full Text] [Related]
12. Comorbidities in patients with non-functioning pituitary adenoma: influence of long-term growth hormone replacement.
Hammarstrand C; Ragnarsson O; Bengtsson O; Bryngelsson IL; Johannsson G; Olsson DS
Eur J Endocrinol; 2018 Oct; 179(4):229-237. PubMed ID: 30299891
[TBL] [Abstract][Full Text] [Related]
13. Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study.
Smith TR; Cote DJ; Jane JA; Laws ER
J Neurosurg Pediatr; 2016 Oct; 18(4):408-412. PubMed ID: 27286443
[TBL] [Abstract][Full Text] [Related]
14. Life expectancy in patients with pituitary adenoma receiving growth hormone replacement.
Olsson DS; Trimpou P; Hallén T; Bryngelsson IL; Andersson E; Skoglund T; Bengtsson BÅ; Johannsson G; Nilsson AG
Eur J Endocrinol; 2017 Jan; 176(1):67-75. PubMed ID: 27770012
[TBL] [Abstract][Full Text] [Related]
15. Replacement therapy with growth hormone and pituitary tumor recurrence: the relevance of the problem.
Losa M; Gatti E; Rossini A; Lanzi R
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):75-8. PubMed ID: 19020392
[TBL] [Abstract][Full Text] [Related]
16. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
[TBL] [Abstract][Full Text] [Related]
17. Progression of pituitary tumours: impact of GH secretory status and long-term GH replacement therapy.
Gasco V; Caputo M; Cambria V; Beccuti G; Caprino MP; Ghigo E; Maccario M; Grottoli S
Endocrine; 2019 Feb; 63(2):341-347. PubMed ID: 30341707
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone treatment and risk of recurrence or progression of brain tumors in children: a review.
Bogarin R; Steinbok P
Childs Nerv Syst; 2009 Mar; 25(3):273-9. PubMed ID: 19142625
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone replacement therapy reduces risk of cancer in adult with growth hormone deficiency: A meta-analysis.
Li Z; Zhou Q; Li Y; Fu J; Huang X; Shen L
Oncotarget; 2016 Dec; 7(49):81862-81869. PubMed ID: 27835910
[TBL] [Abstract][Full Text] [Related]
20. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
